Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study

Marc Rendell, Steven G. Chrysant

Research output: Contribution to journalArticle

8 Scopus citations
Original languageEnglish
Pages (from-to)183-186
Number of pages4
JournalPostgraduate Medicine
Volume123
Issue number4
DOIs
Publication statusPublished - Jul 2011

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this